17 alpha-hydroxyprogesterone caproate has been researched along with Turner Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, Y; Ito, A; Katagiri, Y; Morita, M; Oji, A; Tamaki, Y | 1 |
1 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Turner Syndrome
| Article | Year |
|---|---|
DuoStim: a new option for fertility preservation for a woman with Turner syndrome.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Buserelin; Cryopreservation; Dydrogesterone; Female; Fertility Agents, Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Menotropins; Menstruation Disturbances; Mosaicism; Oocyte Retrieval; Ovarian Reserve; Ovulation Induction; Primary Ovarian Insufficiency; Turner Syndrome; Young Adult | 2020 |